2-(2,5-Dimethoxyphenyl)pyrimidine-5-carboxylic acid

Catalog No.: 
ACRIMO666
CAS No.: 
1266953-75-6
Molecular Formula: 
C13H12N2O4
Molecular Weight: 
260.25
2-(2,5-Dimethoxyphenyl)pyrimidine-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$253.00InquiryInquiry
1g95%$797.00InquiryInquiry
5g95%$3945.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,5-Dimethoxyphenyl)pyrimidine-5-carboxylic acid
IUPAC Name2-(2,5-dimethoxyphenyl)pyrimidine-5-carboxylic acid
MDL No.MFCD19253261
Molecular FormulaC13H12N2O4
Molecular Weight260.25
SMILESO=C(C1=CN=C(C2=CC(OC)=CC=C2OC)N=C1)O
InChI KeyQUCLZMYDCBMFRW-UHFFFAOYSA-N
Synonym2-(2,5-DIMETHOXYPHENYL)PYRIMIDINE-5-CARBOXYLIC ACID;5-Pyrimidinecarboxylic acid, 2-(2,5-dimethoxyphenyl)-
CAS No.1266953-75-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRIMO666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZOJ109 route compound structure diagram
    ACKZOJ109107099-99-0In Stock
  2. Plus
  3. ACSWCP693 route compound structure diagram
    ACSWCP693374068-01-6In Stock
  4. Then
  5. ACRIMO666 route product structure diagram
    ACRIMO6661266953-75-6
Inquiry

2. ACRIMO666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRIMO666 route product structure diagram
    ACRIMO6661266953-75-6
Inquiry

3. ACRIMO666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRIMO666 route product structure diagram
    ACRIMO6661266953-75-6
Inquiry

Comments (0)